Patients with heart failure with reduced ejection fraction who have secondary mitral
regurgitation (SMR) have poorer outcomes and quality of life than those without SMR …

Mitral regurgitation is a prevalent valvular disease, and its management has gained
increasing importance because of the aging population. Although traditional surgery …

Mitral regurgitation (MR) is the most prevalent valvular heart disease and, when left
untreated, results in reduced quality of life, heart failure, and increased mortality. Mitral valve …

Background A risk score was recently derived from the Cardiovascular Outcomes
Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with …

Introduction and objectives Limited data exist on the prognostic usefulness of transthoracic
echocardiography preceding MitraClip for chronic primary mitral regurgitation (MR). We …

Up to half of real-world patients with secondary mitral regurgitation who underwent
transcatheter edge-to-edge repair (TEER) do not meet the highly selective COAPT …

Background A surrogate of right ventricular–pulmonary arterial coupling, the ratio of tricuspid
annular plane systolic excursion (TAPSE) to pulmonary artery systolic pressure (PASP) has …

Aims Patients with mitral regurgitation (MR) present with considerable heterogeneity in
cardiac damage depending on underlying aetiology, disease progression, and …

The diagnosis and management of mitral and tricuspid valve disease have undergone major
changes in the last few years. The expansion of transcatheter interventions and widespread …

Abstract Background and Aims Risk stratification for mitral valve transcatheter edge-to-edge
repair (M-TEER) is paramount in the decision-making process to appropriately select …